메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Minji Choi (Inha University) Jisoo Shin (Inha University) Chae-Eun Lee (Inha University) Joo-Yoon Chung (Inha University) Minji Kim (Inha University) Xiuwen Yan (Guangzhou Medical University) Wen-Hao Yang (China Medical University) Jong-Ho Cha (Inha University)
저널정보
대한생화학·분자생물학회 BMB Reports BMB Reports 제56권 제5호
발행연도
2023.5
수록면
275 - 286 (12page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Cancer immunotherapy has been acknowledged as a new paradigmfor cancer treatment, with notable therapeutic effects oncertain cancer types. Despite their significant potential, clinicalstudies over the past decade have revealed that cancer immunotherapyhas low response rates in the majority of solid tumors. One of the key causes for poor responses is known to be therelatively low immunogenicity of solid tumors. Because mostsolid tumors are immune desert ‘cold tumors’ with antitumorimmunity blocked from the onset of innate immunity, combinationtherapies that combine validated T-based therapies withapproaches that can increase tumor-immunogenicity are beingconsidered as relevant therapeutic options. This review paperfocuses on immunogenic cell death (ICD) as a way of enhancingimmunogenicity in tumor tissues. We will thoroughly reviewhow ICDs such as necroptosis, pyroptosis, and ferroptosiscan improve anti-tumor immunity and outline clinical trialstargeting ICD. Finally, we will discuss the potential of ICD inducersas an adjuvant for cancer immunotherapy.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0